High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population

被引:7
|
作者
Lee, S
Hong, SW
Moon, WC
Oh, MR
Lee, JK
Ahn, CW
Cha, BS
Kim, KR
Lee, HC
Lim, SK
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
[3] GoodGene Inc, Seoul, South Korea
关键词
D O I
10.1089/thy.2005.15.259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Activation of the RET proto-oncogene, located on the long arms of chromosome 10, contributes to the development of thyroid cancers in two different ways. First, somatic rearrangements of RET with variable activation genes are frequently found in papillary thyroid carcinomas. Second, germ-line point mutations are responsible for the development of medullary thyroid carcinomas and multiple endocrine neoplasia type 2 (MEN 2). There are several conflicting reports on the influences of RET expression and RET/PTC rearrangements on the clinical outcome of thyroid cancers. Therefore, the wild-type RET gene expression and RET/PTC-1, RET/PTC-2, RET/PTC-3 rearrangements were examined in thyroid carcinomas and other thyroid diseases. Materials and Methods: Thirty-six papillary thyroid carcinomas (PTCs), 8 follicular thyroid carcinomas (FTCs), 4 anaplastic thyroid carcinomas (ATC), 7 follicular adenomas (FAs), 23 hyperplasias, 6 normal thyroid tissues, and 39 normal portions from each tumor were included in this study. Reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemical analyses were used to identify the RET gene and RET/PTC rearrangements. Results: From the RT-PCR analysis, 68.9% of the PTCs, a single case of FTC, and 22.2% of the hyperplasias expressed the RET gene. No RET gene expression was observed in ATCs, FAs, or normal thyroid tissues. One RET/PTC-1 and one RET/PTC-2 rearrangement were detected in the PTCs. No RET/PTC-3 rearrangement was detected in any specimen. The immunohistochemical results revealed that 66.7% of PTCs, 28.6% of FAs, and 18.2% of hyperplastic thyroid tissue specimens showed high levels of RET protein expression. Neither the normal thyroid tissues nor the FTCs and ATC, showed high levels of RET protein expression. The two methods are agreed in PTC and hyperplastic nodules, but not in FA and FTC. Conclusion: PTCs among Koreans rarely showed RET/PTC rearrangements, but commonly showed increased RET gene expression. Compared to earlier reports indicating that the expression of the RET gene was limited to PTCs, the RET gene was also expressed in hyperplasias in this study.
引用
收藏
页码:259 / 266
页数:8
相关论文
共 50 条
  • [41] Gene expression in thyroid papillary carcinomas.
    Delys, L.
    Detours, V.
    Dequanter, D.
    Andry, G.
    Menhaut, C.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 98 - 98
  • [42] P53 EXPRESSION IN ANAPLASTIC CARCINOMAS ARISING FROM THYROID PAPILLARY CARCINOMAS
    MATIASGUIU, X
    CUATRECASAS, M
    MUSULEN, E
    PRAT, J
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (04) : 337 - 339
  • [43] Prevalence of Thyroid Papillary Carcinoma Is Very High in Korean Acromegalic Patients.
    Kang, H. C.
    Kim, H. K.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [44] LOW-RATE OF RET PROTOONCOGENE ACTIVATION (PTC/RET(TPC)) IN PAPILLARY THYROID CARCINOMAS FROM SAUDI-ARABIA
    ZOU, MJ
    SHI, YF
    FARID, NR
    CANCER, 1994, 73 (01) : 176 - 180
  • [45] High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma
    Lo, CY
    Lam, KY
    Leung, PP
    Luk, JM
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (04) : 545 - 550
  • [46] DETECTION OF RET ONCOGENE ACTIVATION IN HUMAN PAPILLARY THYROID CARCINOMAS BY INSITU HYBRIDIZATION
    FABIEN, N
    PAULIN, C
    SANTORO, M
    BERGER, N
    GRIECO, M
    GALVAIN, D
    BARBIER, Y
    DUBOIS, PM
    FUSCO, A
    BRITISH JOURNAL OF CANCER, 1992, 66 (06) : 1094 - 1098
  • [47] Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese
    Liu, RT
    Chou, FF
    Wang, CH
    Lin, CL
    Chao, FP
    Chung, JC
    Huang, CC
    Wang, PW
    Cheng, JT
    THYROID, 2005, 15 (04) : 326 - 335
  • [48] c-KIT in thyroid papillary carcinomas
    Aydin, Oguz
    Yildiz, Levent
    Kefeli, Mehmet
    Yusksel, Canan
    Sullu, Yurdanur
    TURKISH JOURNAL OF PATHOLOGY, 2006, 22 (01) : 17 - 20
  • [49] Expression of wild type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany
    Mayr, B
    Pötter, E
    Goretzki, P
    Rüschoff, J
    Dietmaier, W
    Hoang-Vu, C
    Dralle, H
    Brabant, G
    LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (01) : 54 - 59
  • [50] RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions
    Collins, BJ
    Chiappetta, G
    Schneider, AB
    Santoro, M
    Pentimalli, F
    Fogelfeld, L
    Gierlowski, T
    Shore-Freedman, E
    Jaffe, G
    Fusco, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08): : 3941 - 3946